Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,2039,52,3.44 [2.37-4.99],6.954428266062258e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,2471,78,2.54 [1.70-3.80],5.749412594490781e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",2417,77,2.55 [2.08-3.12],1.0627840665642572e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,2440,76,14.83 [9.91-22.19],2.6198903231452e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA2,Adenosine deaminase 2,2439,77,3.04 [2.15-4.30],3.668725474043229e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2050,54,4.91 [3.41-7.07],1.0548968692195856e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2441,76,9.36 [5.74-15.27],3.315028060018813e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2482,77,13.93 [7.14-27.20],1.1692500561172088e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2477,77,4.44 [2.62-7.52],3.1658414332372735e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2102,54,8.68 [5.72-13.17],3.2768006751272783e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,2451,77,3.00 [2.14-4.22],2.3806122830069206e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,2440,76,4.92 [3.52-6.88],1.2110635858996787e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,2102,54,2.57 [1.77-3.75],8.906291569175485e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,2474,77,5.71 [3.17-10.28],6.412788219660637e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,2473,78,4.50 [2.86-7.09],8.657135784110102e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADM,Pro-adrenomedullin,2476,78,39.34 [18.53-83.54],1.1982994396609865e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFM,Afamin,2114,54,0.10 [0.04-0.24],5.101419609379236e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFP,Alpha-fetoprotein,2434,76,0.47 [0.34-0.65],6.90165000058811e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,2457,77,3.56 [2.34-5.43],3.459117175461265e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,2379,72,1.74 [1.46-2.07],3.0862522798814315e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRN,Agrin,2474,77,5.88 [4.25-8.14],1.1819702049051463e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRP,Agouti-related protein,2482,77,2.95 [2.01-4.32],3.282743281544416e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK2,Protein AHNAK2,2062,49,3.28 [2.05-5.22],6.166148718156111e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALCAM,CD166 antigen,2486,78,8.04 [3.57-18.10],4.875787365625714e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,2475,78,53.21 [27.49-102.98],4.100855565716553e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANG,Angiogenin,2454,77,4.18 [2.55-6.84],1.3483411714722962e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT2,Angiopoietin-2,2476,78,3.39 [2.21-5.20],2.2958596529585213e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,2470,77,4.29 [2.84-6.49],5.147957421408122e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA5,Annexin A5,2389,73,2.98 [2.14-4.14],9.524606074733316e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC3,Membrane primary amine oxidase,2464,77,8.24 [4.57-14.87],2.329594513158681e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA2,Apolipoprotein A-II,2120,55,3.22 [2.05-5.05],3.474429838855117e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA4,Apolipoprotein A-IV,2114,54,5.72 [3.50-9.35],3.5657865970124813e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AREG,Amphiregulin,2451,77,3.68 [2.71-5.01],1.031309833368095e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,2464,77,8.94 [6.02-13.28],2.0439367947853715e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,2441,76,9.66 [6.08-15.36],9.022045238387662e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,2120,55,13.46 [7.33-24.72],5.0771945257236126e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,2102,54,9.13 [6.03-13.84],1.896678129467956e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,2464,77,7.30 [4.11-12.96],1.1251663017315786e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B2M,Beta-2-microglobulin,2114,54,11.86 [6.91-20.37],3.1396901039422373e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",2474,77,17.86 [11.18-28.51],1.42729064963111e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,2398,75,5.79 [4.04-8.29],9.575363074654398e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,2079,50,7.46 [3.99-13.94],3.1211469596860275e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOC,Brother of CDO,2417,77,8.38 [4.20-16.73],1.6518284099317363e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,2477,77,30.37 [16.92-54.53],2.803501851055576e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,2474,77,11.04 [7.71-15.79],2.06626155670734e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,2454,77,4.81 [3.34-6.93],4.043662331060988e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,2471,77,7.15 [3.86-13.24],4.0520978476838205e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,2451,77,10.94 [7.30-16.38],3.971929859635739e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,2476,78,4.90 [3.35-7.18],2.8857494852745733e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,2486,78,6.40 [3.35-12.21],1.9088409023353403e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB1,Calbindin,2451,77,3.16 [2.26-4.42],1.866599081994512e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB2,Calretinin,2394,74,4.16 [2.80-6.19],1.970325334832468e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCA,Calcitonin,2439,76,2.03 [1.65-2.49],1.7608622701614066e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,2109,53,2.27 [1.75-2.95],6.302801502165596e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,2453,77,7.79 [3.22-18.86],5.290924497111272e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPG,Macrophage-capping protein,2437,77,2.19 [1.65-2.91],5.34195392448111e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,2460,78,4.39 [3.22-5.98],8.779189593755714e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL11,Eotaxin,2482,77,4.10 [2.43-6.92],1.298230332038251e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL14,C-C motif chemokine 14,2454,77,4.17 [2.89-6.00],1.8593429632235085e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL15,C-C motif chemokine 15,2486,78,4.29 [3.05-6.02],4.0677281827035074e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL20,C-C motif chemokine 20,2482,77,1.43 [1.22-1.68],8.890827658821744e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL23,C-C motif chemokine 23,2474,77,2.81 [1.84-4.30],1.9493490971643403e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL25,C-C motif chemokine 25,2482,77,5.09 [3.28-7.90],4.416122160820569e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL3,C-C motif chemokine 3,2454,77,1.54 [1.28-1.84],3.322926161279372e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,2479,78,6.36 [4.59-8.80],6.84563955713101e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,2476,78,5.70 [3.93-8.26],4.634413747555045e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN5,CCN family member 5,2467,77,7.06 [4.70-10.61],5.843187338697415e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,2441,76,0.35 [0.22-0.56],8.796199473051953e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,2422,77,4.62 [3.23-6.62],5.811432029737626e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,2482,77,5.79 [4.28-7.84],4.50642926570881e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164,Sialomucin core protein 24,2467,77,2.47 [1.68-3.64],4.5022694887565964e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200,OX-2 membrane glycoprotein,2454,77,3.38 [2.22-5.14],1.2912650235662986e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD207,C-type lectin domain family 4 member K,2408,74,5.13 [3.21-8.20],7.900153975605161e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD244,Natural killer cell receptor 2B4,2482,77,4.02 [2.21-7.28],4.746449721594573e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,2465,77,7.12 [5.34-9.49],9.164377436623035e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,2441,76,3.14 [2.29-4.29],9.526578898922765e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD276,CD276 antigen,2459,77,7.26 [4.76-11.06],2.90445016788595e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,2398,75,3.26 [2.21-4.82],3.028431521233625e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300A,CMRF35-like molecule 8,2079,50,18.94 [10.03-35.74],1.1573262555038737e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300C,CMRF35-like molecule 6,2480,77,12.04 [7.62-19.02],1.667039557627286e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,2469,78,5.75 [4.11-8.03],1.267089969199974e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LF,CMRF35-like molecule 1,2476,78,3.43 [2.48-4.74],8.79848654717927e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,2467,77,6.76 [4.65-9.82],1.2313924619585746e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,2451,77,11.70 [8.17-16.76],3.8695573010759e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2451,77,9.15 [6.09-13.77],2.0123360435867507e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,2451,77,3.72 [2.67-5.20],1.3135900694320974e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,2445,77,7.94 [4.67-13.49],1.9249586763177133e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD48,CD48 antigen,2470,77,7.45 [4.43-12.54],3.6677493080985935e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,2475,78,3.62 [2.61-5.01],9.912545111858267e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,2368,75,5.70 [3.97-8.18],3.6613756701718715e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,2350,75,15.52 [10.07-23.90],1.6350298400054397e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD7,T-cell antigen CD7,2045,54,3.76 [2.71-5.22],2.4320106988286565e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD70,CD70 antigen,2454,77,2.45 [1.67-3.62],5.550975764270335e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD72,B-cell differentiation antigen CD72,2079,50,3.55 [2.07-6.09],4.06552980583165e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,2480,77,13.08 [8.27-20.70],4.604649415459179e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,2482,77,5.66 [4.28-7.49],6.2768357442412425e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD83,CD83 antigen,2454,77,5.65 [3.69-8.65],1.5758544798001012e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,2386,75,9.00 [5.90-13.73],2.1374893904780862e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,2467,77,46.48 [23.60-91.54],1.2079174641468336e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,2467,77,18.92 [9.60-37.27],1.958508869382557e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,2366,75,3.20 [2.50-4.09],3.360834216814665e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH3,Cadherin-3,2480,77,6.65 [4.68-9.44],4.250735220684031e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH6,Cadherin-6,2460,78,2.93 [1.89-4.53],1.344556262135058e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,2451,77,1.97 [1.65-2.35],9.227577121750096e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDSN,Corneodesmosin,2471,77,5.93 [4.04-8.70],9.096595512534572e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,2102,54,3.46 [2.32-5.15],1.0512087053206055e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,2417,77,2.57 [1.79-3.68],2.8712890859334945e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2079,50,7.84 [4.27-14.37],2.914102843560506e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFC1,Cryptic protein,2398,75,1.85 [1.41-2.42],7.665112222869464e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFD,Complement factor D,2114,54,17.92 [8.69-36.94],5.405660149567609e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,2467,77,2.10 [1.66-2.65],3.815495977507987e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,2460,78,4.50 [3.22-6.28],1.0856420596928718e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2109,53,7.93 [5.55-11.31],3.50763711184345e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,2104,54,4.15 [2.64-6.51],6.115866115179525e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGA,Chromogranin-A,2117,52,1.58 [1.32-1.88],4.043189544454721e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,2473,77,5.64 [4.08-7.81],1.8448870363309345e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,2404,77,1.80 [1.48-2.19],4.712600923583753e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL1,Chordin-like protein 1,2470,77,10.18 [6.45-16.06],2.1310226231910768e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,2470,77,4.81 [3.74-6.17],1.3101704796288475e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKB,Creatine kinase B-type,2117,52,3.38 [2.42-4.71],7.281319991729128e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLC,Galectin-10,2457,78,1.95 [1.52-2.50],1.5249080381244093e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,2441,76,3.98 [2.32-6.82],5.326701229531523e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,2467,77,11.42 [7.70-16.94],8.829404972326288e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,2417,77,7.82 [5.35-11.45],3.590058967571802e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,2454,77,2.39 [1.85-3.07],1.2474702086075604e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,2453,78,6.86 [4.17-11.26],2.950658076682522e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,2398,75,2.92 [2.09-4.10],4.2301779709368487e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,2482,77,7.32 [5.16-10.39],7.56619947981277e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,2476,78,42.43 [24.28-74.17],1.6098865340938093e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,2117,52,11.26 [5.98-21.19],6.198382922040442e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,2460,78,31.57 [17.02-58.54],6.224276658758628e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,2460,78,2.52 [1.81-3.52],5.436676553624988e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,2486,78,8.80 [6.36-12.20],4.099090162510978e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,2459,77,17.44 [11.30-26.93],4.158150276921697e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA4,Carboxypeptidase A4,2024,49,4.17 [2.31-7.54],2.342668991130256e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,2108,54,13.72 [6.54-28.79],4.383602451641073e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,2079,50,4.58 [2.60-8.06],1.3393175710338834e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,2470,77,2.37 [1.72-3.26],1.2071740419560833e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,2459,77,7.41 [3.67-14.94],2.21983358714148e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,2474,77,18.14 [8.33-39.48],2.798803764005986e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIP2,Cysteine-rich protein 2,2441,76,3.64 [2.39-5.56],1.9832354430536198e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,2441,76,2.73 [1.88-3.97],1.294346398005223e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,2474,77,12.04 [7.29-19.89],2.4941313154348423e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,2117,52,5.21 [2.58-10.51],4.132410107565674e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST1,Cystatin-SN,1857,43,1.67 [1.36-2.06],1.5770142485707796e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,2456,76,11.95 [7.88-18.11],1.3600667875213701e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST6,Cystatin-M,2389,77,4.02 [2.83-5.70],7.155520129035086e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSTB,Cystatin-B,2428,76,3.23 [2.12-4.94],5.6786025688803455e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,2117,52,4.58 [2.72-7.71],1.1130325654752965e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSB,Cathepsin B,2455,78,2.66 [1.94-3.65],1.2020815510532103e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSL,Cathepsin L1,2460,78,4.20 [2.30-7.68],2.9777376596195853e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSO,Cathepsin O,2482,77,3.27 [1.94-5.50],8.097830320452516e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSZ,Cathepsin Z,2457,77,6.02 [3.69-9.81],6.303514023419677e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CX3CL1,Fractalkine,2441,76,5.73 [3.97-8.27],1.0894613540189915e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,2454,77,3.89 [2.83-5.35],7.556818307950482e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,2483,78,15.20 [8.01-28.84],8.38334727499738e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,2474,77,2.08 [1.67-2.58],3.650294718192287e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTL1,Cytokine-like protein 1,2117,52,10.51 [5.27-20.94],2.2936553160933718e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2465,77,5.50 [3.32-9.11],3.6690406749766685e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,2417,77,9.31 [5.07-17.10],6.45453274227166e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,2480,77,5.34 [2.80-10.18],3.73771107553271e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,2398,75,2.43 [1.95-3.03],3.4383701874101853e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK3,Dickkopf-related protein 3,2486,78,6.72 [3.71-12.16],3.24346305669462e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,2438,76,4.02 [2.96-5.46],5.194331427817021e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLK1,Protein delta homolog 1,2486,78,2.56 [1.85-3.54],1.3932040083688956e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,2465,77,15.50 [10.30-23.31],1.4245635684369287e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,2062,49,0.42 [0.30-0.60],1.021798991252014e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,2486,78,26.96 [11.98-60.66],1.7017366834392157e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPY30,Protein dpy-30 homolog,2467,78,2.08 [1.59-2.74],1.424531905756269e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRAXIN,Draxin,2441,76,4.46 [3.06-6.52],9.948534444555911e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,2444,76,14.35 [9.06-22.74],7.274612041282631e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG2,Desmoglein-2,2467,77,4.90 [2.99-8.02],2.8011001183316197e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG3,Desmoglein-3,2468,78,5.10 [3.14-8.28],4.4656856018955236e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTNB,Dystrobrevin beta,2100,54,3.89 [2.69-5.64],6.609054332677401e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,2451,77,10.06 [5.61-18.03],9.499544864246424e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBI3_IL27,Interleukin-27,2471,78,7.11 [3.97-12.73],3.915620583197024e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,2476,78,6.69 [5.09-8.79],2.009684557852141e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDN1,Endothelin-1,2062,49,14.42 [6.55-31.74],3.368186497371439e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,2102,54,11.49 [7.18-18.39],2.6748479518870422e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2461,77,10.43 [6.70-16.24],2.7242572780109764e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,2107,54,5.23 [3.47-7.89],2.6587687186548346e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,2465,77,12.35 [8.66-17.62],1.1205674872956718e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,2440,76,10.67 [7.68-14.84],4.9669127997858416e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNB2,Ephrin-B2,2067,53,1.75 [1.38-2.23],4.385160907106408e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELN,Elastin,2108,54,5.67 [3.08-10.44],2.5682942318836404e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,1957,47,4.97 [3.23-7.64],2.9245831748572253e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,2469,77,10.07 [5.76-17.59],5.011703725820112e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,2371,75,7.64 [5.67-10.30],8.831207023369282e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,2079,50,11.38 [4.91-26.40],1.4782942462719038e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,2486,78,13.40 [9.15-19.64],1.64175518095017e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,2439,76,10.25 [6.65-15.79],4.6439177294387677e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2472,78,6.43 [4.12-10.03],2.448488532104056e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,2486,78,8.77 [5.50-13.98],6.59106092970237e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F3,Tissue factor,2462,78,10.41 [5.81-18.68],3.817663900812722e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",2459,77,2.21 [1.86-2.63],3.947023647509025e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",2460,78,1.84 [1.52-2.23],5.311260196304588e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",2108,54,3.65 [2.81-4.74],4.251890274908811e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",2486,78,3.09 [2.40-3.96],9.508211109591426e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,2415,77,2.10 [1.61-2.74],3.5815497615387253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3B,Protein FAM3B,2451,77,8.16 [4.74-14.04],3.801015195522008e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,2460,78,16.95 [10.92-26.31],1.9084160673723304e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3D,Protein FAM3D,2102,54,2.19 [1.62-2.97],4.479536998204012e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,2478,78,2.34 [1.81-3.03],9.925981694203794e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBLN2,Fibulin-2,2117,52,7.65 [4.35-13.46],1.642979839376988e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,2467,77,2.08 [1.62-2.68],1.2005199164610958e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL6,Fc receptor-like protein 6,2454,77,2.05 [1.54-2.72],8.420291753194585e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF23,Fibroblast growth factor 23,2471,78,2.16 [1.78-2.63],1.7412758311076002e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF5,Fibroblast growth factor 5,2398,76,4.80 [3.18-7.25],9.093131453174796e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,2465,77,8.80 [4.76-16.27],4.012917214617117e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGL1,Fibrinogen-like protein 1,2120,55,2.59 [1.82-3.69],1.286936459044096e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2441,76,5.61 [3.67-8.58],1.889616711263794e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,2447,77,2.48 [1.72-3.58],1.15811854953738e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,2109,53,3.57 [2.15-5.94],8.774880388955871e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,2452,77,12.94 [7.91-21.18],2.2871177670166367e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR2,Folate receptor beta,2480,77,6.59 [3.77-11.50],3.5457681017984314e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL1,Follistatin-related protein 1,2062,49,28.13 [9.90-79.89],3.730009639470491e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL3,Follistatin-related protein 3,2460,77,10.33 [7.20-14.83],1.0038472249795396e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS6,Growth arrest-specific protein 6,2470,78,10.91 [5.30-22.46],8.923222907656385e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCG,Pro-glucagon,2398,75,1.55 [1.33-1.81],2.3024625737697483e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2019,48,2.03 [1.50-2.74],4.357597644702727e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,2486,78,3.67 [2.94-4.57],6.097388637685907e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,2471,78,21.61 [14.00-33.34],8.431942046179414e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,2451,77,7.92 [3.40-18.41],1.561473851769446e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,2434,76,8.29 [4.99-13.77],3.287709965079245e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,2441,76,11.77 [6.36-21.78],4.209465555668794e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRL,Appetite-regulating hormone,2460,78,1.75 [1.38-2.21],3.1763251715994e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,2109,53,10.40 [6.05-17.86],2.1593968554970905e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GM2A,Ganglioside GM2 activator,2068,52,5.38 [3.90-7.41],7.608162869136432e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC1,Glypican-1,2476,78,9.79 [5.33-18.00],2.0415728815073289e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,2403,74,6.78 [3.53-13.02],9.474277840855036e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,2417,77,3.96 [3.02-5.20],2.4702065094253985e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRN,Progranulin,2454,77,7.29 [3.79-14.00],2.494045468169013e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRP,Gastrin-releasing peptide,2062,49,2.08 [1.53-2.81],2.595782947782808e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,2459,77,6.86 [5.09-9.26],2.0908902177790248e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,2475,78,3.63 [3.03-4.36],9.542228458169776e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,2467,77,9.47 [6.43-13.96],6.397917853816913e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPH,Hephaestin,2108,54,8.54 [3.30-22.11],9.718520910640603e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,2105,53,2.35 [1.76-3.14],6.590048246010598e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2454,77,7.12 [5.06-10.02],2.0394623323332042e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNMT,Histamine N-methyltransferase,2436,76,2.78 [1.98-3.91],3.6395685341055116e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2062,49,2.46 [1.73-3.48],4.013551506404836e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2050,54,4.28 [2.90-6.33],2.9148766370367105e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,2104,54,5.43 [3.58-8.25],1.897265694626868e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB6,Heat shock protein beta-6,2476,78,5.19 [3.69-7.31],4.319648599158445e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2440,77,10.02 [6.90-14.55],8.626960640270262e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,2486,78,36.04 [18.75-69.29],5.825672756546512e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2056,52,4.79 [2.81-8.15],8.462317070598729e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,2474,77,22.90 [12.26-42.78],9.041096106692104e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,2451,77,10.53 [6.09-18.22],3.8263646535730506e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,2485,78,1.83 [1.55-2.15],3.228782964369084e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,2481,78,3.56 [2.71-4.67],4.631028989809995e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,2443,76,4.73 [3.82-5.86],9.463092500949704e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,2448,76,7.12 [5.19-9.76],4.492456103333313e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,2486,78,4.33 [3.16-5.94],7.096195360466579e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,2460,78,4.15 [2.85-6.04],9.934883834366688e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,2460,78,3.09 [2.22-4.31],2.79457204083134e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,2474,77,9.62 [6.18-14.96],1.0916516696817657e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12A_IL12B,Interleukin-12,2451,77,2.04 [1.65-2.51],4.399796158693917e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12B,Interleukin-12 subunit beta,2482,77,2.74 [1.97-3.82],2.8351176866748202e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,2398,76,4.85 [3.21-7.33],6.136788187594022e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15,Interleukin-15,2454,77,3.32 [1.97-5.62],7.308796095990916e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,2398,76,9.05 [5.63-14.55],8.807889558944373e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17C,Interleukin-17C,2398,76,1.99 [1.67-2.37],1.4494563967663464e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,2464,77,11.78 [7.53-18.43],3.708194511682764e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL19,Interleukin-19,2412,75,1.54 [1.30-1.83],8.164428589856892e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,2465,77,12.98 [6.94-24.26],9.45621451241907e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,2436,76,3.68 [2.76-4.92],1.056777349166877e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,2454,77,4.60 [3.31-6.39],9.413858209862716e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMMT,MICOS complex subunit MIC60,2104,54,2.37 [1.70-3.31],3.534970544005767e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBB,Inhibin beta B chain,2079,50,3.52 [2.44-5.09],1.6723447315313105e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL4,Early placenta insulin-like peptide,2104,54,2.59 [1.93-3.48],2.7440175877661656e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB6,Integrin beta-6,2398,76,4.38 [2.35-8.17],3.4513302303769107e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,2117,52,2.47 [1.71-3.55],1.3306860434330842e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2464,77,3.67 [2.12-6.36],3.46957362992097e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,2480,77,15.06 [10.25-22.15],2.875814372750292e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2451,77,3.04 [1.94-4.76],1.3123999797820326e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,2109,53,7.13 [4.15-12.26],1.2308018835600198e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,2394,74,2.99 [2.00-4.46],8.294821795692602e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KITLG,Kit ligand,2460,78,3.74 [2.30-6.07],1.0357843081803529e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK10,Kallikrein-10,2457,77,2.49 [1.68-3.69],5.666746135848738e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,2439,77,11.76 [7.62-18.14],7.95716335493854e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK14,Kallikrein-14,2476,78,3.19 [2.09-4.86],6.384369198804247e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK4,Kallikrein-4,2476,78,2.51 [2.08-3.02],3.9726877693359003e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK6,Kallikrein-6,2461,77,6.03 [3.77-9.66],7.473982275909419e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK8,Kallikrein-8,2373,74,5.11 [3.55-7.37],2.42011337717646e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,2482,77,7.89 [5.65-11.03],1.1069049021925666e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,2482,77,3.78 [2.59-5.51],5.528780591093707e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,2109,53,3.24 [2.19-4.80],4.074282451753122e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",2449,76,2.43 [1.98-2.97],9.655142423959242e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,2451,77,3.27 [2.37-4.52],7.158353827713475e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2459,77,3.97 [3.17-4.96],1.7413629151365846e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,2439,76,7.71 [5.85-10.16],1.2775053433883543e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN15,Lipocalin-15,2107,54,1.85 [1.49-2.30],3.014183998495013e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,2378,76,3.51 [2.70-4.55],3.0713585070760787e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,2460,78,4.80 [3.01-7.65],4.704419581567363e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3,Galectin-3,2456,77,5.16 [2.76-9.65],2.732402580276804e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,2459,77,3.70 [2.83-4.85],2.041918629050612e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,2447,77,3.60 [2.63-4.94],1.5784498783458646e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS9,Galectin-9,2462,77,8.72 [5.18-14.65],3.120845203889978e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,2454,77,6.46 [3.75-11.14],1.7526845761721595e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2460,78,4.91 [2.71-8.88],1.4102555220928717e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2398,76,4.72 [3.33-6.69],2.828082491746879e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB2,Lamin-B2,2109,53,15.42 [8.44-28.17],5.452434554549914e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD1,Leiomodin-1,2107,54,9.37 [5.85-15.03],1.504108869117432e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,2114,54,8.17 [3.24-20.58],8.360122394750591e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,2460,78,9.28 [6.22-13.84],9.393575222254212e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,2486,78,6.50 [4.16-10.15],2.020987256065975e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,2446,77,9.12 [6.50-12.80],1.6260377355685297e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,2452,77,4.50 [3.39-5.96],1.2617740528324442e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,2108,54,4.75 [2.75-8.22],2.5191647919931443e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,2465,77,11.29 [6.67-19.13],1.9835301247519732e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN2,Matrilin-2,2466,77,5.99 [3.11-11.54],8.997837916142838e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MB,Myoglobin,2486,78,2.13 [1.65-2.75],6.1211672334242735e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDK,Midkine,2458,77,2.05 [1.62-2.60],3.313684827095855e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,2482,77,4.94 [2.51-9.72],3.709301592005845e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,2486,78,6.74 [4.43-10.25],4.2584849171473743e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,2465,77,3.47 [2.23-5.40],3.8514814459116644e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLN,Promotilin,2454,77,1.88 [1.47-2.41],4.917416374395871e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP10,Stromelysin-2,2458,77,2.92 [2.18-3.92],6.722657708681754e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP12,Macrophage metalloelastase,2461,78,2.69 [1.97-3.65],3.029004479780181e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP3,Stromelysin-1,2467,77,2.59 [1.91-3.50],6.06062668624301e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,2413,77,7.10 [4.98-10.12],2.4717448432774448e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,2476,78,6.46 [4.06-10.27],3.501287400391878e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRC1,Macrophage mannose receptor 1,2120,55,8.84 [4.09-19.09],2.8982537313608933e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,2454,76,2.31 [1.79-2.97],8.13902609764927e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,2480,77,3.29 [2.19-4.94],9.880198157184313e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC13,Mucin-13,2394,74,2.12 [1.65-2.74],6.0432978644209234e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2067,53,2.03 [1.57-2.63],9.32578222979856e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,2470,77,2.18 [1.55-3.07],7.287748073819467e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,2055,49,0.30 [0.18-0.50],3.876500160160571e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,2465,77,21.24 [13.29-33.95],2.3697666410440903e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,2451,77,6.75 [4.85-9.39],1.1977132367232272e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2102,54,12.22 [6.99-21.37],1.6581049660097134e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,2476,78,14.06 [7.76-25.46],2.742949411162785e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,2460,78,10.47 [7.30-15.01],2.359759544967465e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,2465,77,4.71 [3.72-5.96],7.563172883602781e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,2387,73,3.57 [2.86-4.44],1.1225927703539909e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,2465,77,0.34 [0.23-0.51],2.0686458230762089e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFASC,Neurofascin,2482,77,5.87 [3.37-10.21],3.887446008549554e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",2394,74,2.71 [2.10-3.48],9.925234088096404e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,2486,78,12.21 [4.06-36.73],8.406711944979933e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,2117,52,14.08 [6.07-32.64],7.09278416269465e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,2486,78,4.23 [2.63-6.82],2.988425177460161e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,2082,52,16.43 [9.37-28.80],1.4781647143711574e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,2460,78,6.39 [4.73-8.64],1.351252594355321e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPB,Natriuretic peptides B,2417,77,1.44 [1.27-1.64],9.541917817718724e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPC,C-type natriuretic peptide,2454,77,2.20 [1.71-2.84],1.031657992534278e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPY,Pro-neuropeptide Y,2476,78,2.45 [1.76-3.41],9.336417570135093e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP1,Neuropilin-1,2464,77,5.15 [2.74-9.71],3.858371113027575e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,2109,53,3.99 [2.85-5.59],7.559880221511814e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,2460,78,1.61 [1.43-1.82],1.4439621205733323e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUCB2,Nucleobindin-2,2474,78,4.60 [2.94-7.20],2.2593877942272525e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH1,Neurexophilin-1,2394,74,2.31 [1.59-3.34],9.382838440321018e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH3,Neurexophilin-3,2050,54,16.22 [7.18-36.67],2.148791277953423e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OCLN,Occludin,2107,54,7.09 [4.60-10.93],6.6007901497117675e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,2467,77,6.42 [4.85-8.50],1.7711153230325576e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,2466,77,6.77 [3.96-11.57],2.594475661030024e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM,Paralemmin-1,2093,54,9.73 [6.08-15.57],2.251021202157936e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM2,Paralemmin-2,2109,53,8.30 [5.17-13.33],1.8291285847434614e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,2477,78,14.99 [7.21-31.19],4.357360672974902e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2102,54,5.42 [3.11-9.45],2.412609726668419e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH1,Protocadherin-1,2470,77,3.71 [2.14-6.42],3.0073582017963724e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH7,Protocadherin-7,2102,54,3.90 [2.67-5.71],2.286251237681009e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1,Programmed cell death protein 1,2474,78,2.56 [1.86-3.53],1.0070535795168333e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,2451,77,6.39 [4.43-9.22],3.263939549913661e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,2460,78,5.72 [3.44-9.53],1.9712281257380912e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,2079,50,6.41 [3.25-12.64],8.242622260474634e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PENK,Proenkephalin-A,2079,50,9.41 [5.69-15.58],2.7427602284767232e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,2482,77,13.39 [8.98-19.98],4.764816405512365e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,2473,78,3.07 [2.21-4.27],2.9281024626354186e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,2102,54,4.65 [3.07-7.03],3.605644807354688e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2441,76,7.66 [4.59-12.81],7.656645684159309e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI16,Peptidase inhibitor 16,2120,55,23.43 [8.40-65.36],1.6913283659351683e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,2424,77,2.17 [1.78-2.64],8.094898391284595e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,2435,76,4.77 [3.08-7.40],3.0620073178592162e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2467,77,13.02 [9.29-18.25],3.90445176249782e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,2467,77,7.61 [4.73-12.23],5.534039467915005e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,2460,78,3.66 [2.44-5.50],3.626544811436136e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,2446,77,12.21 [7.53-19.81],3.5577012202215464e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB2,Plexin-B2,2472,77,4.20 [2.42-7.28],3.359458003564805e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,2465,77,5.85 [3.31-10.33],1.127668700912481e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POF1B,Protein POF1B,2050,54,2.83 [1.90-4.22],3.513249995214787e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2451,77,2.39 [1.72-3.31],2.0432238216656202e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPL,Periplakin,2050,54,4.19 [2.44-7.21],2.280083980380127e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2107,54,3.16 [2.33-4.28],1.620184068901805e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,2117,52,6.35 [3.08-13.10],5.467595071803112e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,2398,76,2.49 [1.69-3.69],4.593051284822814e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRELP,Prolargin,2459,77,6.60 [3.80-11.46],2.118047122113754e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG2,Bone marrow proteoglycan,2117,52,3.90 [2.61-5.82],2.8773856222697427e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRND,Prion-like protein doppel,2109,53,2.83 [1.88-4.28],7.458576902573998e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,2062,49,4.83 [3.31-7.07],4.3605386358133774e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS22,Brain-specific serine protease 4,2050,54,2.31 [1.67-3.20],4.4375620320167573e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,2453,78,3.34 [2.12-5.27],1.937164037110573e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS8,Prostasin,2456,77,5.44 [3.56-8.33],6.138263602213541e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAP,Prosaposin,2098,52,13.62 [6.64-27.95],1.0836763635721765e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,2102,54,2.70 [1.83-3.97],5.429677817436311e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,2435,77,6.78 [5.04-9.12],1.5621029962298928e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2454,77,2.18 [1.65-2.89],5.75101930930807e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,2394,74,4.85 [3.10-7.60],5.20126736111063e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2436,76,6.87 [4.64-10.17],6.7092396811247485e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,2109,53,4.93 [3.13-7.77],6.319174455223049e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,2486,78,7.24 [4.54-11.56],1.0266065708984842e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,2460,78,15.39 [8.45-28.04],4.027536495234735e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,2398,75,3.15 [2.06-4.80],1.0384400965339985e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,2464,77,2.41 [1.70-3.39],5.880008996857919e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,2107,54,2.88 [2.32-3.57],5.136907117897478e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,2451,77,2.16 [1.80-2.59],8.988970930317133e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP5,Retinol-binding protein 5,2451,77,2.23 [1.66-3.00],1.0212227184331841e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,2440,76,3.98 [3.15-5.02],5.848226004062251e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1B,Lithostathine-1-beta,2486,78,2.99 [2.39-3.74],7.773499022192588e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,2486,78,2.77 [2.23-3.44],3.006453129455829e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,2466,77,4.00 [3.00-5.34],5.648731566061972e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,2467,77,11.83 [8.09-17.30],3.366695753051725e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,2460,78,1.80 [1.52-2.14],2.0402477647141848e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RETN,Resistin,2456,78,2.94 [2.19-3.95],6.457235595506613e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMA,Repulsive guidance molecule A,2480,77,6.22 [3.55-10.90],1.6261765546820834e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,2480,77,12.11 [7.64-19.18],2.4297693507830527e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,2120,55,14.18 [7.70-26.10],1.6777219835503954e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,2062,49,3.17 [2.05-4.92],2.3138192266975965e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE4,Ribonuclease 4,2044,54,7.09 [4.31-11.66],1.2471433452621756e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE6,Ribonuclease K6,2106,55,2.75 [2.08-3.64],1.5681373900580002e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,2478,78,5.07 [3.81-6.75],1.118280112956568e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,2062,49,13.33 [7.74-22.96],9.324560813249914e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2460,78,11.48 [6.83-19.29],3.127592334520652e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO1,R-spondin-1,2441,76,3.85 [2.24-6.63],1.1226809387836158e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,2476,78,8.89 [5.90-13.38],1.365218161523455e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTBDN,Retbindin,2451,77,9.32 [5.53-15.71],5.208911933321532e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4R,Reticulon-4 receptor,2476,78,6.54 [4.40-9.74],1.9649870835056904e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A4,Protein S100-A4,2465,77,0.46 [0.33-0.65],9.05166690265263e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SBSN,Suprabasin,2110,52,4.58 [2.60-8.04],1.2340080121784237e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,2480,77,13.11 [8.54-20.12],5.123694496888035e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,2389,76,8.38 [6.17-11.37],2.671501047788652e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,2480,77,7.20 [5.03-10.31],3.5137053768028034e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,2468,78,12.12 [7.78-18.86],2.144306149364766e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG3,Secretogranin-3,2466,77,4.01 [2.28-7.07],1.4589345942903117e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB1A1,Uteroglobin,2466,77,4.05 [2.74-5.96],1.7069290353046117e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,2398,76,3.52 [2.54-4.86],2.7258267416717526e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,2062,49,5.01 [3.31-7.59],2.5481037015969743e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,2108,54,9.23 [4.72-18.05],8.519664554682379e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC1,Syndecan-1,2460,78,3.56 [2.60-4.88],2.5407002988496207e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC4,Syndecan-4,2460,78,0.40 [0.27-0.60],8.968551028826305e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,2062,49,3.87 [2.62-5.70],8.963126171912193e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3F,Semaphorin-3F,2460,78,12.36 [6.47-23.60],2.6033361582245352e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN8,Septin-8,2106,53,6.26 [3.90-10.04],2.966788989109935e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,2081,54,8.19 [3.34-20.07],4.31013891174027e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,2465,77,7.38 [4.76-11.43],3.965529111003236e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,2437,76,2.32 [1.80-2.98],4.9070387476162166e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHISA5,Protein shisa-5,2117,52,11.34 [7.38-17.44],1.799306237505181e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC1,Sialoadhesin,2474,77,3.79 [2.59-5.52],5.162329439248556e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,2454,77,4.45 [3.17-6.25],5.5535408999989794e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,2467,77,2.11 [1.63-2.74],2.0283829653459856e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,2476,78,4.52 [2.67-7.64],1.9560206998899483e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,2454,77,4.91 [3.51-6.87],1.6305493170228046e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,2398,76,2.52 [1.88-3.37],6.54589192734074e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF7,SLAM family member 7,2454,77,2.13 [1.61-2.82],1.1939740717992993e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF8,SLAM family member 8,2398,75,2.31 [1.61-3.33],6.65903128320411e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,2394,74,2.09 [1.67-2.62],1.493025973321636e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,2454,77,3.42 [2.53-4.62],9.257172244760517e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,2476,78,3.73 [2.29-6.07],1.3222882824156278e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,2417,77,5.94 [4.03-8.76],2.034374040822192e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,2099,52,4.15 [2.89-5.94],1.0361862858835051e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,2476,78,4.24 [2.66-6.74],1.1047072336282748e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,2474,77,5.14 [3.77-7.00],4.93516277133859e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCG,Gamma-synuclein,2441,76,3.81 [2.95-4.93],1.5058229276274547e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,2398,75,7.78 [5.39-11.22],5.567426625252602e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARCL1,SPARC-like protein 1,2452,76,4.58 [2.57-8.18],2.591591180469294e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,2467,77,4.97 [3.83-6.46],3.975120105377612e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,2079,50,7.33 [4.12-13.05],1.2336178716627732e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,2454,77,3.00 [2.43-3.72],5.275459193022264e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,2467,77,7.28 [4.53-11.71],2.7872790589126543e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,2476,78,3.16 [2.14-4.68],8.065780297178156e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,2461,77,3.86 [2.20-6.75],2.327174731507156e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,2474,77,3.49 [2.32-5.24],1.836441655518789e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON1,Spondin-1,2466,77,6.05 [4.14-8.82],9.904496125140191e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON2,Spondin-2,2453,78,12.37 [7.92-19.33],2.2252683920367153e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPP1,Osteopontin,2481,78,3.81 [2.77-5.23],1.4848547339148108e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR3,Small proline-rich protein 3,2109,53,2.16 [1.59-2.93],7.958182158600204e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2451,77,1.98 [1.47-2.67],6.367710393934739e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,2070,50,9.20 [4.74-17.87],5.711664606819503e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYT1,Synaptotagmin-1,2109,53,2.20 [1.64-2.95],1.487325422090747e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,2174,70,5.27 [2.90-9.57],4.6329301418523913e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,2451,77,7.85 [5.59-11.02],1.0829972236376308e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,2440,76,0.63 [0.52-0.76],1.2952888199150214e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN2,Transcobalamin-2,2481,78,6.72 [4.46-10.13],8.11326087423854e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX101,Testis-expressed protein 101,2067,53,2.37 [1.63-3.45],6.601482576226933e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,2456,77,2.28 [1.93-2.70],2.980659118154632e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF2,Trefoil factor 2,2470,77,2.59 [2.08-3.22],1.846298818728324e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,2459,77,2.15 [1.54-3.00],7.449258662212742e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFA,Protransforming growth factor alpha,2454,77,2.69 [1.94-3.73],2.842911087757975e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,2050,54,4.61 [2.35-9.04],9.156991568419534e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,2465,77,5.83 [4.51-7.52],1.4718072737130254e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,2486,78,6.85 [4.51-10.42],2.281702316914924e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,2120,55,16.34 [9.49-28.14],7.1794467667547e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,2460,78,6.66 [4.66-9.53],2.5773186788056976e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,2480,77,12.86 [7.82-21.16],8.45115009847917e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,2422,76,5.71 [3.97-8.20],4.2097023449464174e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,2467,77,2.62 [1.75-3.92],3.1446341313439464e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,2457,78,13.05 [6.11-27.88],3.209512920658815e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,2106,53,3.91 [2.70-5.67],6.55909252549833e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNF,Tumor necrosis factor,2416,77,2.53 [2.00-3.21],1.5125153153199656e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2441,76,3.71 [2.90-4.74],1.191988814854051e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2441,76,1.76 [1.56-1.99],6.76816411342709e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2482,77,7.59 [5.65-10.19],1.8824854435038403e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2465,77,8.87 [6.17-12.76],5.538369297715783e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2466,77,3.80 [2.89-5.01],1.5854602890966768e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2466,77,7.24 [5.30-9.89],1.1161174073695832e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2079,50,4.40 [2.44-7.94],8.831753718070034e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2476,78,7.17 [5.36-9.60],3.4095261950309236e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2467,77,14.83 [10.30-21.35],1.126942819347426e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2467,77,2.51 [2.13-2.94],9.063884912378143e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2480,77,20.05 [11.74-34.22],4.4533199079837675e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2477,77,6.39 [4.63-8.83],2.6733624054759245e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2441,76,2.64 [2.07-3.38],1.0433282452464484e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2480,77,2.95 [2.09-4.15],6.095426739197529e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2441,76,3.46 [2.77-4.31],4.256380114622451e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,2474,77,8.66 [4.64-16.17],1.2075850463701322e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",2417,77,1.63 [1.31-2.03],9.744091540072304e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPMT,Thiopurine S-methyltransferase,2398,75,0.50 [0.37-0.68],5.599512480869669e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML2,Trem-like transcript 2 protein,2467,77,3.37 [2.06-5.51],1.3909900573604108e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2050,54,3.32 [2.08-5.30],5.38847163669982e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ULBP2,UL16-binding protein 2,2441,76,8.69 [5.94-12.71],8.001490724549592e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UMOD,Uromodulin,2475,77,0.33 [0.25-0.43],3.491037436319387e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,2109,53,2.64 [1.86-3.75],5.7601032200619295e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASN,Vasorin,2420,77,6.94 [4.16-11.59],1.2192214265662346e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,2463,77,6.32 [3.70-10.81],1.5640409652940413e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,2479,77,4.00 [2.63-6.09],1.087700923047844e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VGF,Neurosecretory protein VGF,2107,54,4.15 [2.63-6.57],1.167070821836284e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIT,Vitrin,2108,54,3.16 [1.90-5.26],9.29833479319999e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,2451,77,3.09 [2.25-4.24],2.5517969329502505e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,2104,54,2.19 [1.68-2.86],8.88537535310818e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,2462,76,8.04 [5.86-11.03],4.225312950712394e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,2438,76,9.47 [6.35-14.13],3.13380163957994e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,2473,78,2.06 [1.59-2.67],5.611783417018452e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,2335,70,6.19 [4.72-8.11],5.5883343979697665e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2466,77,4.13 [2.36-7.22],6.857087262569422e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,2398,76,3.28 [2.45-4.39],1.3543112801283773e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XCL1,Lymphotactin,2476,78,2.07 [1.63-2.62],1.8368199952098327e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,2474,78,7.99 [5.65-11.28],5.191172754377244e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,2109,53,22.52 [12.41-40.88],1.3155753702521931e-24
